We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 115

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 1 2014

The U.S. Food and Drug Administration (FDA) seeks input "on the design and conduct of the postmarketing requirements (PMRs) for the class-wide

Study shows rise in biotech patent litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 20 2012

PricewaterhouseCoopers LLP has released its “2012 Patent Litigation Study,” which shows that the 4,105 patent lawsuits filed in 2011 marked a high point and a 22-percent increase from the previous year

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 6 2012

Heads of the U.S. Patent and Trademark Office (USPTO), European Patent Office and Japan Patent Officecollectively known as the Trilateral Offices confirm their commitment to eliminating unnecessary duplication of work, enhancing patent examination and quality, and working to ensure that stable patent rights can be granted smoothly and easily worldwide

U.S. Supreme Court to consider just one question in Myriad Genetics

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 6 2012

The U.S. Supreme Court has agreed to review a Federal Circuit Court of Appeals ruling on the patentability of human genes and limited its grant of certiorari to the question “Are human genes patentable?”

Do DNA patents affect genetic sequencing and testing advances?

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 15 2012

University of Missouri-Kansas City School of Law Professor Christopher Holman writes in the most recent issue of Nature Technology that while DNA sequencing technology has spawned a myriad of patent-related lawsuits, “aggressive patent acquisition and enforcement practices” show no signs of abating and may not necessarily be hindering the development of next-generation DNA sequencing and analysis technologies

CRS visiting scholar recommends that Congress clarify patentable subject matter doctrine

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 15 2012

In a Congressional Research Service paper titled “Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine,” visiting scholar John Thomas considers how the U.S. Supreme Court ruling limiting the patentability of diagnostic methods that simply describe natural phenomena and relations may affect innovation and public health

News Bytes - July 11, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 11 2013

The White House issues its "2013 Joint Strategic Plan on Intellectual Property Enforcement." Among other things, the plan calls for an increased

FTC issues report on “pay-for-delay” agreements

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 24 2013

The U.S. Federal Trade Commission (FTC) has published an overview of fiscal year 2012 agreements resolving "patent disputes between a brand and a

News bytes - February 21, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 21 2013

The U.S. Patent and Trademark Office schedules a series of public roundtables "to solicit stakeholder input on ways the agency can reduce the number

Myriad Genetics sues diagnostics company over BRCA1 and BRCA2 testing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 11 2013

Just weeks after the U.S. Supreme Court determined that naturally occurring human genes are not patent eligible and thus found certain Myriad